Literature DB >> 8327700

Assessment of breast cancer recurrence with contrast-enhanced subtraction MR imaging: preliminary results in 26 patients.

R Gilles1, J M Guinebretière, L G Shapeero, A Lesnik, G Contesso, D Sarrazin, J Masselot, D Vanel.   

Abstract

Local relapse was suspected in 26 women treated conservatively for breast cancer. All women underwent routine magnetic resonance (MR) imaging and a dynamic MR subtraction study after injection of gadolinium-tetraazacyclododecanetetra-acetic acid. Twelve women had no local relapse. Surgical biopsy enabled confirmation of recurrence in 14 patients. Routine MR imaging did not allow differentiation of recurrence from glandular or scar tissue. Except for one case of fat necrosis, patients without local relapse showed no contrast enhancement 1 minute 34 seconds after injection. At dynamic MR imaging, all recurrences showed contrast enhancement 1 minute 34 seconds after injection. Nodular enhancement (n = 11) was found in invasive carcinoma, whereas linear enhancement was seen in intraductal carcinoma (n = 3). Subtraction of precontrast from postcontrast images always allowed better visualization of contrast enhancement. Contrast-enhanced subtraction dynamic MR imaging may prove to be accurate in diagnosis of local relapses of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8327700     DOI: 10.1148/radiology.188.2.8327700

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  16 in total

Review 1.  Integration of breast imaging into cancer management.

Authors:  L J Esserman; D Wolverton; N Hylton
Journal:  Curr Oncol Rep       Date:  2000-11       Impact factor: 5.075

2.  [Suspected contrast medium concentration in dynamic MR-mammography. Post-traumatic fracture of the ribs].

Authors:  A Fink; K Wasser; D Aufderstrasse; H Ludemann; S Delorme
Journal:  Radiologe       Date:  2002-09       Impact factor: 0.635

Review 3.  Imaging tumour angiogenesis.

Authors:  Tony Jeswani; Anwar R Padhani
Journal:  Cancer Imaging       Date:  2005-12-01       Impact factor: 3.909

Review 4.  Advances in breast imaging: magnetic resonance imaging.

Authors:  Lia Bartella; Elizabeth A Morris
Journal:  Curr Oncol Rep       Date:  2006-01       Impact factor: 5.075

Review 5.  Optical tomography with ultrasound localization for breast cancer diagnosis and treatment monitoring.

Authors:  Quing Zhu; Susan Tannenbaum; Scott H Kurtzman
Journal:  Surg Oncol Clin N Am       Date:  2007-04       Impact factor: 3.495

6.  Detection of suspected malignant patterns in three-dimensional magnetic resonance breast images.

Authors:  E A el-Kwae; J E Fishman; M J Bianchi; P M Pattany; M R Kabuka
Journal:  J Digit Imaging       Date:  1998-05       Impact factor: 4.056

7.  Utilizing optical tomography with ultrasound localization to image heterogeneous hemoglobin distribution in large breast cancers.

Authors:  Quing Zhu; Scott H Kurtzma; Poornima Hegde; Susan Tannenbaum; Mark Kane; Minming Huang; Nan Guang Chen; Bipin Jagjivan; Kristen Zarfos
Journal:  Neoplasia       Date:  2005-03       Impact factor: 5.715

8.  Follow-up of women with breast cancer: comparison between MRI and FDG PET.

Authors:  Gerhard W Goerres; Sven C A Michel; Mathias K Fehr; Achim H Kaim; Hans C Steinert; Burkhardt Seifert; Gustav K von Schulthess; Rahel A Kubik-Huch
Journal:  Eur Radiol       Date:  2002-11-13       Impact factor: 5.315

9.  FDG-PET and other imaging modalities for the evaluation of breast cancer recurrence and metastases: a meta-analysis.

Authors:  LingLing Pan; Yuan Han; XiaoGuang Sun; JianJun Liu; Huang Gang
Journal:  J Cancer Res Clin Oncol       Date:  2010-01-21       Impact factor: 4.553

10.  Prediction of pathological complete response of breast cancer patients undergoing neoadjuvant chemotherapy: usefulness of breast MRI computer-aided detection.

Authors:  H Kim; H H Kim; J S Park; H J Shin; J H Cha; E Y Chae; W J Choi
Journal:  Br J Radiol       Date:  2014-08-27       Impact factor: 3.039

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.